// App-Quantinova.ai

934 : Development of Myelodysplastic Syndrome and Acute Leukemias in Patients with Monoclonal Gammopathy of Undetermined Significance (MGUS): A Population-Based Study of 17,315 Patients

Researchers

Presenter

  • Dirk Larson

Principal Investigators

  • Robert A. Kyle

  • Shaji K. Kumar

  • Angela Dispenzieri

  • S. Vincent Rajkumar

Medical Centers

  • Statistics, Mayo Clinic, Rochester, MN

Locations

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Endocrine/metabolic Diseases (ME)

Disease

  • Acute lymphoblastic leukemia

  • Alpha-thalassemia myelodysplasia syndrome

  • Hematological malignancies

  • Acute myelocytic leukemia

  • Monoclonal gammopathy

  • Multiple Myeloma

  • Acute Leukemia

Biomarkers

  • Breakpoint Cluster Region

  • Cluster of differentiation 79A

  • Immunoglobulin G

  • Tyrosine 3-Monooxygenase/Tryptophan 5-Monooxygenase Activation Protein Epsilon

  • Monoclonal gammopathy of undetermined significance

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • double blind/blinded

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim

Copyright © 2026. QuantiNova All rights reserved